CLINICAL_TRIALS ClinicalTrials.gov record update

A Randomized, Double-Blind, Placebo Controlled Trial of Aldafermin (NGM282) for Treatment of Chronic Diarrhea Due to Bile Acid Malabsorption (BAM)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT05130047
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:39:32.278278+00:00
Published At: 2023-10-12T00:00:00+00:00
Record Updated At: 2023-10-12
Results Posted At: 2023-10-12
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Chronic Diarrhea", "Irritable Bowel Syndrome With Diarrhea", "Bile Acid Malabsorption", "Bile Acid Diarrhea", "Bile Acid Malabsorption Syndrome Type II", "Functional Diarrhea"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2023-10-12"
protocolSection.identificationModule.nctId: "NCT05130047"
protocolSection.identificationModule.officialTitle: "A Randomized, Double-Blind, Placebo Controlled Trial of Aldafermin (NGM282) for Treatment of Chronic Diarrhea Due to Bile Acid Malabsorption (BAM)"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2023-10-12"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.